{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:15:20Z","timestamp":1775067320395,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.7759\/cureus.106279","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:31:48Z","timestamp":1775061108000},"source":"Crossref","is-referenced-by-count":0,"title":["Bevacizumab as Rescue Therapy for GI Bleeding in Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.7759","author":[{"given":"Abay A","family":"Gobezie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Adidam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mekdem","family":"Bisrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrawit W","family":"Zinabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wondwossen","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalkidan S","family":"Alayu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naga Sai Shravan","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Aduli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angesom","family":"Kibreab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam B","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan ME","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW, et al.. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020, 173:989-1001. 10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182136d32","article-title":"Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis","volume":"13","author":"McDonald J","year":"2011","unstructured":"McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med. 2011, 13:607-16. 10.1097\/GIM.0b013e3182136d32","journal-title":"Genet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4719-3","article-title":"Gastrointestinal manifestations of hereditary hemorrhagic telangiectasia (HHT): a systematic review of the literature","volume":"62","author":"Jackson SB","year":"2017","unstructured":"Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D. Gastrointestinal manifestations of hereditary hemorrhagic telangiectasia (HHT): a systematic review of the literature. Dig Dis Sci. 2017, 62:2623-30. 10.1007\/s10620-017-4719-3","journal-title":"Dig Dis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2018.0253","article-title":"The impact of small bowel endoscopy in patients with hereditary hemorrhagic telangiectasia","volume":"35","author":"Zammit SC","year":"2018","unstructured":"Zammit SC, Sanders DS, McAlindon ME, Sidhu R. The impact of small bowel endoscopy in patients with hereditary hemorrhagic telangiectasia. Turk J Haematol. 2018, 35:300-14. 10.4274\/tjh.2018.0253","journal-title":"Turk J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/a-2190-9303","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: long-term results of endoscopic treatment","volume":"11","author":"Manfredi G","year":"2023","unstructured":"Manfredi G, Crin\u00f2 SF, Alicante S, et al.. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: long-term results of endoscopic treatment. Endosc Int Open. 2023, 11:1145-52. 10.1055\/a-2190-9303","journal-title":"Endosc Int Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari H","year":"2021","unstructured":"Al-Samkari H, Kasthuri RS, Parambil JG, et al.. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2021, 106:2161-9. 10.3324\/haematol.2020.261859","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod S","year":"2012","unstructured":"Dupuis-Girod S, Ginon I, Saurin JC, et al.. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012, 307:948-55. 10.1001\/jama.2012.250","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2242178","article-title":"Management of refractory gastrointestinal bleeding in hereditary hemorrhagic telangiectasia with bevacizumab","volume":"2021","author":"Masood M","year":"2021","unstructured":"Masood M, Coles M, Sifuentes H. Management of refractory gastrointestinal bleeding in hereditary hemorrhagic telangiectasia with bevacizumab. Case Rep Gastrointest Med. 2021, 2021:10.1155\/2021\/2242178","journal-title":"Case Rep Gastrointest Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12832","article-title":"Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"285","author":"Al-Samkari H","year":"2019","unstructured":"Al-Samkari H, Kritharis A, Rodriguez-Lopez JM, Kuter DJ. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. J Intern Med. 2019, 285:223-31. 10.1111\/joim.12832","journal-title":"J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.3.192","article-title":"Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab","volume":"49","author":"Wee JW","year":"2014","unstructured":"Wee JW, Jeon YW, Eun JY, Kim HJ, Bae SB, Lee KT. Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab. Blood Res. 2014, 49:192-5. 10.5045\/br.2014.49.3.192","journal-title":"Blood Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara N","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003, 9:669-76. 10.1038\/nm0603-669","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin CL","year":"2010","unstructured":"Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24:203-19. 10.1016\/j.blre.2010.07.001","journal-title":"Blood Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.19","article-title":"Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis","volume":"109","author":"Jackson CS","year":"2014","unstructured":"Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis. Am J Gastroenterol. 2014, 109:474-83. 10.1038\/ajg.2014.19","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470965-bevacizumab-as-rescue-therapy-for-gi-bleeding-in-hereditary-hemorrhagic-telangiectasia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:31:48Z","timestamp":1775061108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470965-bevacizumab-as-rescue-therapy-for-gi-bleeding-in-hereditary-hemorrhagic-telangiectasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.106279","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}